Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00509-4/abstract?dgcid=raven_jbs_etoc_feature_lancet